147 related articles for article (PubMed ID: 11464893)
1. Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: a report from the European Neuroblastoma Study Group "Survey".
Cotterill SJ; Pearson AD; Pritchard J; Kohler JA; Foot AB;
Med Pediatr Oncol; 2001 Jan; 36(1):235-8. PubMed ID: 11464893
[TBL] [Abstract][Full Text] [Related]
2. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group 'Survey' 1982-1992.
Cotterill SJ; Pearson AD; Pritchard J; Foot AB; Roald B; Kohler JA; Imeson J
Eur J Cancer; 2000 May; 36(7):901-8. PubMed ID: 10785596
[TBL] [Abstract][Full Text] [Related]
3. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastoma--a surgical perspective.
Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
[TBL] [Abstract][Full Text] [Related]
5. Salvage rates after progression of high-risk neuroblastoma with a soft tissue mass.
Murphy JM; Lim II; Farber BA; Heaton TE; Basu EM; Roberts SS; Modak S; Kushner BH; LaQuaglia MP
J Pediatr Surg; 2016 Feb; 51(2):285-8. PubMed ID: 26651282
[TBL] [Abstract][Full Text] [Related]
6. Reasonable surgery for thoracic neuroblastoma in infants and children.
Catalano PW; Newton WA; Williams TE; Clatworthy HW; Kilman JW
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):459-64. PubMed ID: 703352
[TBL] [Abstract][Full Text] [Related]
7. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
[TBL] [Abstract][Full Text] [Related]
8. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
[TBL] [Abstract][Full Text] [Related]
9. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
10. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the risk factor for the poor prognosis of localized neuroblastoma after the surgical.
Zhou K; Li XL; Pan J; Xu JZ; Wang J
Medicine (Baltimore); 2018 Oct; 97(40):e12718. PubMed ID: 30290678
[TBL] [Abstract][Full Text] [Related]
13. Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma.
Ashraf K; Shaikh F; Gibson P; Baruchel S; Irwin MS
Pediatr Blood Cancer; 2013 Oct; 60(10):1636-41. PubMed ID: 23650219
[TBL] [Abstract][Full Text] [Related]
14. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
15. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.
Basta NO; Halliday GC; Makin G; Birch J; Feltbower R; Bown N; Elliott M; Moreno L; Barone G; Pearson AD; James PW; Tweddle DA; McNally RJ
Br J Cancer; 2016 Oct; 115(9):1048-1057. PubMed ID: 27701387
[TBL] [Abstract][Full Text] [Related]
17. Improved survival of children with neuroblastoma between 1979 and 2005: a report of the Italian Neuroblastoma Registry.
Haupt R; Garaventa A; Gambini C; Parodi S; Cangemi G; Casale F; Viscardi E; Bianchi M; Prete A; Jenkner A; Luksch R; Di Cataldo A; Favre C; D'Angelo P; Zanazzo GA; Arcamone G; Izzi GC; Gigliotti AR; Pastore G; De Bernardi B
J Clin Oncol; 2010 May; 28(14):2331-8. PubMed ID: 20351331
[TBL] [Abstract][Full Text] [Related]
18. Experience with aortic grafting during excision of large abdominal neuroblastomas in children.
Paran TS; Corbally MT; Gross-Rom E; Rutigliano DN; Kayton ML; La Quaglia MP
J Pediatr Surg; 2008 Feb; 43(2):335-40. PubMed ID: 18280285
[TBL] [Abstract][Full Text] [Related]
19. Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry.
Garaventa A; Parodi S; De Bernardi B; Dau D; Manzitti C; Conte M; Casale F; Viscardi E; Bianchi M; D'Angelo P; Zanazzo GA; Luksch R; Favre C; Tamburini A; Haupt R
Eur J Cancer; 2009 Nov; 45(16):2835-42. PubMed ID: 19616426
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
